Filing Details
- Accession Number:
- 0000950170-25-070568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-13 17:43:42
- Reporting Period:
- 2025-05-09
- Filing Date:
- 2025-05-13
- Accepted Time:
- 2025-05-13 17:43:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1756262 | Transmedics Group Inc. | TMDX | Electromedical & Electrotherapeutic Apparatus (3845) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1773661 | M Edward Basile | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-05-09 | 6,000 | $0.70 | 6,732 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-05-09 | 6,000 | $115.63 | 732 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2025-05-09 | 6,000 | $0.00 | 6,000 | $0.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,285 | 2026-02-16 | No | 4 | M | Direct |
Footnotes
- The option is fully vested.
- The Stock Option reported herein as being disposed of is an option to purchase common stock of TransMedics, Inc. Immediately prior to the closing of the Issuer's initial public offering, pursuant to the terms of the Merger Agreement, each outstanding option to purchase shares of common stock of TransMedics, Inc. was converted into an outstanding option to purchase shares of common stock of the Issuer adjusted on a 3.5-for-one basis, with a corresponding adjustment to the exercise price.